Helen M. Thackray
Overview
Helen M. Thackray received $7M in total compensation, including $425K in salary, at BioCryst Pharmaceuticals in 2021. Helen Thackray also received an average of $1M at GlycoMimetics from 2013 to 2019.
- 2021
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
BioCryst PharmaceuticalsChief R&D Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
GlycoMimeticsChief Medical Officer
Source: SEC filings on April 25, 2022, April 16, 2020, April 10, 2019, April 13, 2018, April 20, 2017, April 11, 2016, and June 15, 2015.
Related executives
We found 22 more executives who work or worked at BioCryst Pharmaceuticals and GlycoMimetics.
Harout Semerjian
GlycoMimetics
Chief Executive Officer
Brian Hahn
GlycoMimetics
Chief Financial Officer
Edwin Rock
GlycoMimetics
Chief Medical Officer
Armand Girard
GlycoMimetics
Former Chief Business Officer and Senior Vice President
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
William Sheridan
BioCryst Pharmaceuticals